OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 37 filers reported holding OCULAR THERAPEUTIX INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $54,000 | +12.5% | 6,508 | -7.6% | 0.00% | – |
| Q3 2016 | $48,000 | +92.0% | 7,044 | +37.6% | 0.00% | – |
| Q2 2016 | $25,000 | -49.0% | 5,119 | 0.0% | 0.00% | – |
| Q1 2016 | $49,000 | +36.1% | 5,119 | +32.4% | 0.00% | – |
| Q4 2015 | $36,000 | -64.7% | 3,867 | -46.6% | 0.00% | – |
| Q3 2015 | $102,000 | -26.6% | 7,236 | +9.8% | 0.00% | – |
| Q2 2015 | $139,000 | +21.9% | 6,591 | +143.3% | 0.00% | – |
| Q1 2015 | $114,000 | +128.0% | 2,709 | +26.5% | 0.00% | – |
| Q4 2014 | $50,000 | +6.4% | 2,141 | -31.2% | 0.00% | – |
| Q3 2014 | $47,000 | – | 3,111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $31,590 | 100.00% |
| Opaleye Management Inc. | 5,780,000 | $29,824,800 | 7.13% |
| DELTEC ASSET MANAGEMENT LLC | 1,974,797 | $10,189,953 | 2.23% |
| Lynwood Capital Management Inc. | 262,500 | $1,354,500 | 1.72% |
| Endurant Capital Management LP | 368,438 | $1,901,140 | 1.66% |
| Knoll Capital Management, LLC | 200,000 | $1,032,000 | 1.25% |
| Knoll Capital Management, LLC | 95,800 | $814,300 | 0.99% |
| SECTORAL ASSET MANAGEMENT INC | 802,680 | $4,141,829 | 0.69% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 300,977 | $1,553,041 | 0.22% |
| Cormorant Asset Management, LP | 645,000 | $3,328,200 | 0.19% |